Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Change in Accured Expenses (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Change in Accured Expenses for 4 consecutive years, with $566000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 179.49% to $566000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 63.89% year-over-year, with the annual reading at $4.9 million for FY2025, 63.89% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $566000.0 at Orchestra BioMed Holdings, down from $3.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.7 million in Q2 2024, with the low at -$1.8 million in Q1 2023.
  • Average Change in Accured Expenses over 4 years is $708250.0, with a median of $617000.0 recorded in 2023.
  • The sharpest move saw Change in Accured Expenses tumbled 988.61% in 2023, then surged 378.31% in 2024.
  • Over 4 years, Change in Accured Expenses stood at $1.1 million in 2022, then plummeted by 53.4% to $493000.0 in 2023, then plummeted by 244.42% to -$712000.0 in 2024, then skyrocketed by 179.49% to $566000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $566000.0, $3.4 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.